BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24452548)

  • 1. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
    Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
    Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
    Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
    J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer.
    Gao Y; Chen F; Niu S; Lin S; Li S
    Medicine (Baltimore); 2015 Sep; 94(36):e1246. PubMed ID: 26356687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population.
    Matsuse M; Takahashi M; Mitsutake N; Nishihara E; Hirokawa M; Kawaguchi T; Rogounovitch T; Saenko V; Bychkov A; Suzuki K; Matsuo K; Tajima K; Miyauchi A; Yamada R; Matsuda F; Yamashita S
    J Med Genet; 2011 Sep; 48(9):645-8. PubMed ID: 21730105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
    Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
    Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
    Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
    Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.
    Ai L; Liu X; Yao Y; Yu Y; Sun H; Yu Q
    Endocrine; 2014 Nov; 47(2):428-34. PubMed ID: 24723258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXE1 association with differentiated thyroid cancer and its progression.
    Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
    Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population.
    Zhang Q; Song F; Zheng H; Zhu X; Song F; Yao X; Zhang L; Chen K
    Thyroid; 2013 Jan; 23(1):38-44. PubMed ID: 22973979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.
    Jendrzejewski J; He H; Radomska HS; Li W; Tomsic J; Liyanarachchi S; Davuluri RV; Nagy R; de la Chapelle A
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8646-51. PubMed ID: 22586128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common genetic variant on 14q13.3 contributes to thyroid cancer susceptibility: evidence based on 12 studies.
    Zheng J; Li C; Wang C; Ai Z
    Mol Genet Genomics; 2015 Jun; 290(3):1125-33. PubMed ID: 25552255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
    Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
    Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
    Park SW; Kim MK; Kwon KH; Kim J
    Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
    Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
    Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas.
    Shuxian J; Xiaoyun C; Zhihui F; Xiaohua L; Zhanhui D; Bin H; Lin Z
    Thyroid; 2014 May; 24(5):867-71. PubMed ID: 24308748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
    Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.